Louis Chen

Stock Analyst at Cantor Fitzgerald

(n/a)

# 4,339

Out of 4,667 analysts

10

Total ratings

n/a

Success rate

-71.48%

Average return

Main Sectors:

Top Industries:

Medical Devices Biotechnology

Stocks Rated by Louis Chen

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	CATX Perspective Therapeutics	Reiterates: Overweight	n/a	$6.17	-	8	Sep 10, 2024
	THTX Theratechnologies	Reiterates: Overweight	$36	$1.22	+2,850.82%	2	Jul 13, 2023

Perspective Therapeutics

Sep 10, 2024

Reiterates: Overweight

Price Target: n/a

Current: $6.17

Upside: -

Theratechnologies

Jul 13, 2023

Reiterates: Overweight

Price Target: $36

Current: $1.22

Upside: +2,850.82%